Future-proof your approach to disclosure.

In the modern clinical trial landscape, what’s compliant today may not be compliant tomorrow. And what’s considered groundbreaking transparency this quarter may be outdated the next.

Let us help you stay one step ahead — by building best practices for ongoing disclosure compliance into your policies and operations. We leverage over a decade of working closely with registries, regulators, and patient advocates to help you disclose all your pertinent information correctly, promptly, seamlessly.

With TrialScope Advisory Services:

Get crystal clarity
on where you stand

There are two sides to the trial compliance story: how you perform internally, and how you’re perceived by the public. We assess both with a comprehensive, data-driven review and analysis. See how well your trials comply with U.S. and EU regulations, past and present. Afterward, get a report isolating areas for improvement.

Identify potential gaps in policies and processes

How do your disclosure policies and processes compare with other sponsors? How accurately do they reflect your commitments to patients and the community? We conduct a comprehensive evaluation of all policies, standard operating procedures (SOPs), guidelines, and checklists to identify opportunities, address compliance gaps, and recommend changes for the better.

Build compliance into the
way you work

Finally, we thoroughly evaluate your existing (or draft) standard operating procedures — to ensure they keep your company compliant, align with industry transparency trends, and incorporate best practices. By the time your SOPs are finished and implemented, maintaining ongoing compliance will be second nature for your team.

“Our recent partnership with TrialScope has clearly demonstrated our lack of expertise around disclosure and provided us with important information that was lacking before the partnership that otherwise would have taken us longer to realize. I believe the partnership will enable us to move toward increased transparency.”

Rare Disease Biotech Company

Sr. Director, Clinical Processes and Systems

Be ready for whatever comes next.

Disclosure is always evolving — let us give you the expert guidance
you need to stay up to date.